Boston Partners’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
MF
AAM
TAL
PCMI
AIC
WIC
Boston Partners's NPTN Position: Q1 2022 in Review
Boston Partners sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 22,573 shares — an estimated $347K sold.
Boston Partners first reported a position in NPTN in Q3 2014 and held it in 20 quarters. The position peaked at $17.8M in Q4 2018. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.
- Boston Partners reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
- Boston Partners sold 22,573 NEOPHOTONICS CORP shares in Q1 2022, an estimated $347K.
- Boston Partners first reported a position in NEOPHOTONICS CORP in Q3 2014 and held it in 20 quarters.
- Boston Partners's NEOPHOTONICS CORP position peaked at $17.8M in Q4 2018.
- 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.
Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.